Title : Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque-triggered thrombus formation in humans.

Pub. Date : 2018 Jun 14

PMID : 29559479






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 GPIb and GPVI signal through Bruton tyrosine kinase (Btk), which can be blocked irreversibly by oral application of ibrutinib, an established therapy for chronic lymphocytic leukemia (CLL) with long-term safety. ibrutinib glycoprotein VI platelet Homo sapiens
2 We found that ibrutinib and the novel Btk inhibitors acalabrutinib and ONO/GS-4059 block GPVI-dependent static platelet aggregation in blood exposed to human plaque homogenate and collagen but not to ADP or arachidonic acid. ibrutinib glycoprotein VI platelet Homo sapiens